Knowledge (XXG)

Template:Antirheumatic products

Source 📝

37: 184: 47: 30: 227: 306: 201: 189: 91: 86: 15: 135: 78: 231: 101: 195: 300: 241: 145: 122: 68: 169: 157: 51: 140: 131: 126: 106: 164: 152: 96: 60: 269:
will show the template collapsed, i.e. hidden apart from its title bar.
234:), it is hidden apart from its title bar; if not, it is fully visible. 226:, meaning that if there is another collapsible item on the page (a 19: 293:
will show the template expanded, i.e. fully visible.
272: 248: 115: 77: 59: 237:To change this template's initial visibility, the 31: 8: 38: 24: 16: 221:initial visibility currently defaults to 238: 7: 232:table with the collapsible attribute 14: 1: 323: 179: 277:Antirheumatic products 253:Antirheumatic products 92:Sodium aurothiosulfate 307:Drug templates by ATC 87:Sodium aurothiomalate 50:products / DMARDs ( 206:Never to phase III 136:Hydroxychloroquine 216: 215: 79:Gold preparations 314: 292: 291: 287: 284: 281: 278: 275: 268: 267: 263: 260: 257: 254: 251: 240: 239:|state= 224: 219:This template's 40: 33: 26: 17: 322: 321: 317: 316: 315: 313: 312: 311: 297: 296: 289: 285: 282: 279: 276: 273: 265: 261: 258: 255: 252: 249: 228:navbox, sidebar 222: 217: 212: 211: 196:Clinical trials 175: 111: 102:Aurothioglucose 73: 55: 44: 12: 11: 5: 320: 318: 310: 309: 299: 298: 295: 294: 270: 214: 213: 210: 209: 208: 207: 204: 193: 187: 181: 180: 177: 176: 174: 173: 161: 149: 143: 138: 129: 119: 117: 113: 112: 110: 109: 104: 99: 94: 89: 83: 81: 75: 74: 72: 71: 65: 63: 57: 56: 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 319: 308: 305: 304: 302: 271: 247: 246: 245: 244:may be used: 243: 235: 233: 229: 225: 205: 203: 200: 199: 197: 194: 191: 188: 186: 183: 182: 178: 171: 167: 166: 162: 159: 155: 154: 150: 147: 146:Sulfasalazine 144: 142: 139: 137: 133: 130: 128: 124: 123:Penicillamine 121: 120: 118: 114: 108: 105: 103: 100: 98: 95: 93: 90: 88: 85: 84: 82: 80: 76: 70: 69:Oxycinchophen 67: 66: 64: 62: 58: 53: 49: 48:antirheumatic 41: 36: 34: 29: 27: 22: 21: 18: 236: 223:autocollapse 220: 218: 170:Azathioprine 163: 158:Methotrexate 151: 23: 192:from market 141:Leflunomide 132:Chloroquine 127:Bucillamine 107:Aurotioprol 165:thiopurine 153:antifolate 61:Quinolines 264:collapsed 242:parameter 202:Phase III 190:Withdrawn 97:Auranofin 46:Specific 301:Category 288:expanded 185:WHO-EM 283:state 259:state 230:, or 116:Other 52:M01C 172:) # 303:: 290:}} 274:{{ 266:}} 250:{{ 198:: 160:#) 134:#/ 125:#/ 286:= 280:| 262:= 256:| 168:( 156:( 148:# 54:) 39:e 32:t 25:v

Index

v
t
e
antirheumatic
M01C
Quinolines
Oxycinchophen
Gold preparations
Sodium aurothiomalate
Sodium aurothiosulfate
Auranofin
Aurothioglucose
Aurotioprol
Penicillamine
Bucillamine
Chloroquine
Hydroxychloroquine
Leflunomide
Sulfasalazine
antifolate
Methotrexate
thiopurine
Azathioprine
WHO-EM
Withdrawn
Clinical trials
Phase III
navbox, sidebar
table with the collapsible attribute
parameter

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.